pHOXBIO

pHOXBIO is a private biopharmaceutical company that has developed pHOXGEN and pHOXWELL, two unique solutions for the prevention of airborne respiratory viruses (ARV), such as coronaviruses and influenza viruses, which cause some of the world's deadliest infectious diseases. pHOXBIO is committed to leveraging scientific breakthroughs to develop drugs and health products to protect society from the spread of airborne respiratory viruses that lead to some of the world’s most fatal infectious diseases. We believe our new solutions have the potential to help control one of the greatest public health challenges of our generation and enhance preparedness for future challenges that may arise from SARS-CoV-2 and its mutations.